(CWEB) Direxion Daily CSI China - NYSE
ETF Category: Trading--Leveraged Equity | Exchange: NYSE (USA) | Market Cap: 223m USD | Total Return: -43.1% in 12m
Avg Turnover: 15.3M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The Direxion Daily CSI China Internet Bull 2X Shares (CWEB) is a leveraged exchange-traded fund designed to provide 200% of the daily performance of the CSI Overseas China Internet Index. The fund allocates at least 80% of its assets to financial derivatives, such as swap agreements and index-tracking securities, to achieve its magnification objective. As a non-diversified vehicle, it focuses specifically on China-based companies within the internet and internet-related sectors.
The underlying index tracks companies involved in e-commerce, social media, and online gaming, industries characterized by high platform scalability and regulatory sensitivity within the Chinese market. These businesses typically operate under an asset-light model, relying on network effects to drive user acquisition and monetization. For a deeper look at specific valuation metrics, you can explore the data on ValueRay.
Since its inception in 2016, CWEB has functioned as a tactical trading tool rather than a long-term investment due to the effects of daily rebalancing and compounding. The fund’s micro-cap status and leveraged structure make it highly sensitive to volatility in the broader Chinese technology sector.
- China stimulus measures drive domestic consumer spending and tech valuations
- Regulatory environment for platform economy firms shifts toward stability
- US-China trade tensions and ADR delisting risks impact investor sentiment
- Leveraged 2X exposure amplifies volatility in underlying Chinese internet constituents
As of June 12, 2026, the stock is trading at USD 22.59 with a total of 837,935 shares traded.
Over the past week, the price has changed by -4.08%,
over one month by -20.74%,
over three months by -26.85% and
over the past year by -43.07%.
Direxion Daily CSI China has no consensus analysts rating.